MedTrace Logo

Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial

NCT00395226 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2011-06-30

Study results available
· View outcomes & findings →

Summary

Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The signs of rosacea are usually confined to the face, but may appear on the neck, scalp or trunk. Opthalmologic findings are also common. Rosacea is usually described as being most common in fair skinned women over 40. The purpose of the study is to determine whether oral Zinc Sulfate treatment is an effective treatment for facial rosacea.

Conditions

  • Rosacea

Interventions

DRUG

zinc sulfate

zinc sulfate 220 mg bis for 90 days

DRUG

placebo

placebo bid for 90 days

Sponsors & Collaborators

  • Essentia Health

    lead OTHER

Principal Investigators

  • Joel Bamford, MD · Essentia Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00395226 on ClinicalTrials.gov